1. Amrein R, Lorscheid T, Stabl M, Schmid-Burgk W (1992) Interactions of moclobe- mide with concomitantly administered medication: evidence from pharmacological and clinical studies. Psychopharmacology 106 [Suppl]: S 24–31
2. Bakish D, Bradwejn J, Nair N, et al (1992) A comparison of moclobemide, amitripty- line and placebo in depression: a Canadian multicentre study. Psychopharmacology 106: S 98–101
3. Becker T, Struck M, Laux G (1989) Depressionsbehandlung mit MAO-A-Inhibitoren: offene Studie zur Direktumstellung von Moclobemid auf tri-/tetrazyklische Antidepressiva. PsychiatPrax 16 [Suppl]: 44–47
4. Bieck PR, Antonin KH (1989) Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitors. J Neural Transm [Suppl] 28: 21–31
5. Blackwell B (1981) Adverse effects of antidepressant drugs, part I. Monoamine oxidase inhibitors and tricyclics. Drugs 21: 201–219